Get the Stockscreener App
200.38
0.72%
1.42
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Quest Diagnostics Inc stock is traded at $200.38, with a volume of 114.23K.
It is up +0.72% in the last 24 hours and up +0.59% over the past month.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
See More
Previous Close:
$198.96
Open:
$199.49
24h Volume:
114.23K
Relative Volume:
0.12
Market Cap:
$22.02B
Revenue:
$11.04B
Net Income/Loss:
$1.04B
P/E Ratio:
22.87
EPS:
8.7626
Net Cash Flow:
$1.36B
1W Performance:
+2.25%
1M Performance:
+0.59%
6M Performance:
+10.17%
1Y Performance:
+21.96%
1-Day Range:
$198.99
$201.00
1-Week Range:
$194.09
$201.00
52-Week Range:
$157.20
$213.50
Quest Diagnostics Inc Stock (DGX) Company Profile
Name
Quest Diagnostics Inc
Sector
Industry
Phone
(973) 520-2700
Address
500 PLAZA DRIVE, SECAUCUS
Compare DGX vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
200.39 | 21.86B | 11.04B | 1.04B | 1.36B | 8.7626 |
TMO
Thermo Fisher Scientific Inc
|
481.75 | 181.35B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
189.78 | 135.96B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
573.47 | 45.86B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
113.62 | 32.45B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
301.63 | 29.83B | 3.17B | 642.63M | 516.49M | 10.77 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-26 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-25-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-02-25 | Initiated | Redburn Atlantic | Buy |
| Mar-04-25 | Downgrade | Citigroup | Buy → Neutral |
| Jan-06-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-17-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-23-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-28-24 | Resumed | Evercore ISI | In-line |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Dec-12-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-29-23 | Initiated | Piper Sandler | Neutral |
| May-02-23 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-03-23 | Upgrade | Citigroup | Sell → Neutral |
| Jan-23-23 | Initiated | Evercore ISI | In-line |
| Nov-17-22 | Downgrade | Citigroup | Neutral → Sell |
| Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
| Feb-23-22 | Downgrade | UBS | Buy → Neutral |
| Feb-02-22 | Downgrade | Jefferies | Buy → Hold |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| May-04-21 | Upgrade | UBS | Neutral → Buy |
| Mar-12-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-21-20 | Upgrade | Argus | Hold → Buy |
| Jul-29-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-09-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jun-02-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-28-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Mar-27-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-19-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jul-15-19 | Downgrade | Goldman | Neutral → Sell |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Mar-18-19 | Resumed | Credit Suisse | Neutral |
| Jan-31-19 | Downgrade | Argus | Buy → Hold |
| Jan-17-19 | Initiated | UBS | Neutral |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-30-18 | Downgrade | Goldman | Buy → Neutral |
View All
Quest Diagnostics Inc Stock (DGX) Latest News
Quest Diagnostics Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Executive pay, performance and board votes at Quest Diagnostics (NYSE: DGX) - Stock Titan
5,900 Shares in Quest Diagnostics Incorporated $DGX Purchased by Capital Management Associates Inc - MarketBeat
Quest Diagnostics Incorporated: - marketscreener.com
Drug Screening Market Trends 2026–2031: Chromatography and Mass Spectrometry Held a 44.77% Share in 2025 Amid Growing Demand for Advanced Testing, Reports Mordor Intelligence - GlobeNewswire Inc.
Quest Diagnostics (DGX) director defers pay into 198 phantom stock units - Stock Titan
Quest Diagnostics Incorporated (DGX) Stock Price, News, Quote & History - Yahoo! Finance Canada
A Look At Quest Diagnostics (DGX) Valuation As Investors Reassess The Stock Without A Clear News Catalyst - Yahoo Finance
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock - Yahoo Finance
Justices Pass On FCA Suit Alleging Quest Diagnostics Fraud - Law360
Eastern Bank Takes Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Assenagon Asset Management S.A. Buys 19,361 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Inc. stock outperforms competitors despite losses on the day - MarketWatch
Vanguard (DGX) amends 13G, reports 0 shares after Jan 12, 2026 realignment - Stock Titan
Quest Diagnostics Earnings Preview: What to Expect - Yahoo Finance
Quest Diagnostics Incorporated $DGX Shares Acquired by SG Americas Securities LLC - MarketBeat
DGX SEC FilingsQuest Diagnostics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Quest Diagnostics Incorporated (NYSE:DGX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Quest Diagnostics (DGX) down 4.2% since last earnings report: Can it rebound? - MSN
Union Bancaire Privee UBP SA Acquires 8,744 Shares in Quest Diagnostics - National Today
8,744 Shares in Quest Diagnostics Incorporated $DGX Acquired by Union Bancaire Privee UBP SA - MarketBeat
Paradiem LLC Buys New Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics to Report Q1 2026 Financial Results on April 21 - intellectia.ai
Quest Diagnostics to Release First Quarter Financial Results on April 21, 2026 - GuruFocus
Quest Diagnostics schedules April 21 earnings release, 8:30 a.m. call - Stock Titan
How Is Quest Diagnostics’ Stock Performance Compared to Other Healthcare Stocks? - Yahoo Finance
Davis Selected Advisers Acquires 7,192 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Zacks Industry Outlook Features Quest Diagnostics, DaVita, Option Care Health, and Addus HomeCare - Bitget
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare - Zacks Investment Research
Danica Pension Livsforsikringsaktieselskab Buys Shares of 70,846 Quest Diagnostics Incorporated $DGX - MarketBeat
Achmea Investment Management B.V. Grows Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Helio Genomics to Make HelioLiver™ Cancer Test Accessible to Quest Diagnostics' Providers - Yahoo Finance
4 Outpatient Home Health Stocks Gaining Attention Amid Market Shifts - TradingView
Quest Diagnostics Incorporated $DGX Shares Sold by Chevy Chase Trust Holdings LLC - MarketBeat
A Look At Quest Diagnostics (DGX) Valuation After Recent Share Price Softness - Yahoo Finance
Aquatic Capital Management LLC Has $8.06 Million Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
EdgePoint Investment Group Inc. Grows Position in Quest Diagnostics Incorporated $DGX - MarketBeat
CSM Advisors LLC Sells 20,078 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Crawford Investment Counsel Inc. Purchases 9,473 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Incorporated $DGX Stock Position Increased by 8 Knots Management LLC - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Sees Large Decrease in Short Interest - MarketBeat
iSAM Funds UK Ltd Invests $1.47 Million in Quest Diagnostics Incorporated $DGX - MarketBeat
Integral Health Asset Management LLC Sells 65,000 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Elects Wentworth to Board of Directors - New Jersey Business Magazine
Korea Investment CORP Sells 14,900 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Elects Timothy Wentworth, Former CEO of Walgreens Boots Alliance, Evernorth Health Services and Express Scripts, to Board of Directors - Sahm
Quest Diagnostics adds ex-Walgreens CEO to board By Investing.com - Investing.com India
Quest Diagnostics Elects Timothy Wentworth to Board of Directors - citybiz
Quest Diagnostics Elects Former Walgreens Boots Alliance CEO Timothy Wentworth to Board of Directors - Minichart
Quest Diagnostics (DGX) Appoints Timothy Wentworth to Board of D - GuruFocus
Quest Diagnostics Inc Stock (DGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.04%
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):